Molecular Data Statistics
Total Valuation
Molecular Data has a market cap or net worth of 1,218.
| Market Cap | 1,218 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Molecular Data has 12.18 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 12.18M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 3.66% |
| Float | 10.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.93
| Current Ratio | 0.93 |
| Quick Ratio | 0.55 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -43.34 |
Financial Efficiency
Return on equity (ROE) is -4,936.16% and return on invested capital (ROIC) is -168.48%.
| Return on Equity (ROE) | -4,936.16% |
| Return on Assets (ROA) | -21.43% |
| Return on Invested Capital (ROIC) | -168.48% |
| Return on Capital Employed (ROCE) | 682.69% |
| Revenue Per Employee | 3.79M |
| Profits Per Employee | -209,626 |
| Employee Count | 189 |
| Asset Turnover | 5.98 |
| Inventory Turnover | 1,286.58 |
Taxes
In the past 12 months, Molecular Data has paid 230,754 in taxes.
| Income Tax | 230,754 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 21.85 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 48.13 |
| Average Volume (20 Days) | 2,692 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 11.64 |
Income Statement
In the last 12 months, Molecular Data had revenue of 715.39 million and -39.62 million in losses. Loss per share was -4.00.
| Revenue | 715.39M |
| Gross Profit | -414,737 |
| Operating Income | -41.03M |
| Pretax Income | -39.36M |
| Net Income | -39.62M |
| EBITDA | -40.14M |
| EBIT | -41.03M |
| Loss Per Share | -4.00 |
Balance Sheet
The company has 54.09 million in cash and 15.80 million in debt, giving a net cash position of 38.28 million or 3.14 per share.
| Cash & Cash Equivalents | 54.09M |
| Total Debt | 15.80M |
| Net Cash | 38.28M |
| Net Cash Per Share | 3.14 |
| Equity (Book Value) | -9.11M |
| Book Value Per Share | -0.93 |
| Working Capital | -8.97M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is -0.06%, with operating and profit margins of -5.73% and -5.54%.
| Gross Margin | -0.06% |
| Operating Margin | -5.73% |
| Pretax Margin | -5.50% |
| Profit Margin | -5.54% |
| EBITDA Margin | -5.61% |
| EBIT Margin | -5.73% |
| FCF Margin | n/a |
Dividends & Yields
Molecular Data does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -3,252,818.88% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 23, 2022. It was a reverse split with a ratio of 0.0666667.
| Last Split Date | May 23, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.0666667 |
Scores
Molecular Data has an Altman Z-Score of 3.54 and a Piotroski F-Score of 1.
| Altman Z-Score | 3.54 |
| Piotroski F-Score | 1 |